CL2018003075A1 - Composiciones nutritivas para la protección cardíaca en animales de compañía. - Google Patents
Composiciones nutritivas para la protección cardíaca en animales de compañía.Info
- Publication number
- CL2018003075A1 CL2018003075A1 CL2018003075A CL2018003075A CL2018003075A1 CL 2018003075 A1 CL2018003075 A1 CL 2018003075A1 CL 2018003075 A CL2018003075 A CL 2018003075A CL 2018003075 A CL2018003075 A CL 2018003075A CL 2018003075 A1 CL2018003075 A1 CL 2018003075A1
- Authority
- CL
- Chile
- Prior art keywords
- company
- animal
- pets
- dmvd
- cardiac protection
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000747 cardiac effect Effects 0.000 title 1
- 230000000050 nutritive effect Effects 0.000 title 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 210000004115 mitral valve Anatomy 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 1
- 239000006014 omega-3 oil Substances 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 229960003080 taurine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A23K50/48—Moist feed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
MÉTODO PARA TRATAR LA ENFERMEDAD DEGENERATIVA DE LA VÁLVULA MITRAL (DMVD) EN UN ANIMAL DE COMPAÑÍA QUE LA TIENE, MÉTODO PARA PREVENIR LA DMVD EN UN ANIMAL DE COMPAÑÍA EN RIESGO DE SUFRIRLA, Y MÉTODO PARA MANTENER O MEJORAR LA SALUD CARDÍACA EN UN ANIMAL DE COMPAÑÍA. INCLUYEN ADMINISTRAR A DICHO ANIMAL POR VÍA ORAL UNA COMPOSICIÓN QUE CONTIENE TRIGLICÉRIDOS DE CADENA MEDIA Y, OPCIONALMENTE, UNO O MÁS DE ÁCIDOS GRASOS OMEGA-3, VIT. E, LISINA, TAURINA, MAGNESIO O AMINOÁCIDOS QUE CONTIENEN AZUFRE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662339436P | 2016-05-20 | 2016-05-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2018003075A1 true CL2018003075A1 (es) | 2018-12-07 |
Family
ID=58993169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2018003075A CL2018003075A1 (es) | 2016-05-20 | 2018-10-29 | Composiciones nutritivas para la protección cardíaca en animales de compañía. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20170332686A1 (es) |
EP (1) | EP3458046B1 (es) |
JP (1) | JP6920343B2 (es) |
CN (1) | CN109069465B (es) |
AU (1) | AU2017267615B2 (es) |
BR (1) | BR112018072064B8 (es) |
CA (1) | CA3021169A1 (es) |
CL (1) | CL2018003075A1 (es) |
ES (1) | ES2851923T3 (es) |
HU (1) | HUE053622T2 (es) |
MX (1) | MX2018014083A (es) |
NZ (1) | NZ746681A (es) |
PL (1) | PL3458046T3 (es) |
RU (1) | RU2744134C2 (es) |
WO (1) | WO2017199223A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018219877A1 (en) * | 2017-05-29 | 2018-12-06 | Nestec S.A. | Medium chain fatty acids for use in the prevention or treatment of cardiac enlargement and/or valvular heart disease |
EP3709817B1 (en) | 2017-11-17 | 2022-11-16 | Hill's Pet Nutrition, Inc. | Compositions comprising omega-3 polyunsaturated and medium chain fatty acids |
BR112020021671A2 (pt) * | 2018-06-07 | 2021-01-26 | Société des Produits Nestlé S.A. | métodos e composições para aumentar os corpos cetônicos em animais |
US20210228594A1 (en) * | 2018-08-22 | 2021-07-29 | Christina Theodoris | Methods for treating cardiac valve disease |
CN109007397A (zh) * | 2018-08-23 | 2018-12-18 | 广东仁源生物科技有限公司 | 一种可以改善小鼠心脏形态结构与功能的饲料组合物及其制备方法 |
MX2021006183A (es) * | 2018-12-27 | 2021-06-18 | Nestle Sa | Composiciones y metodos para diagnosticar y tratar la enfermedad degenerativa de la valvula mitral en un canino. |
CA3128189A1 (en) | 2019-02-01 | 2020-08-06 | Mars, Incorporated | Feline food composition |
WO2020193291A1 (en) * | 2019-03-22 | 2020-10-01 | Société des Produits Nestlé S.A. | Methods using administration of medium chain triglycerides (mct) prior to a meal to increase ketone production from the mcts |
JP2022534471A (ja) * | 2019-05-31 | 2022-08-01 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 動物における健康効果を提供するためのmctベースの栄養ブレンド |
GB201908111D0 (en) * | 2019-06-06 | 2019-07-24 | Mars Inc | Modulation of the oral microbiota |
CN116634882A (zh) | 2020-12-22 | 2023-08-22 | 希尔氏宠物营养品公司 | 宠物食品组合物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4920098A (en) * | 1986-09-17 | 1990-04-24 | Baxter International Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases |
AU784852B2 (en) * | 2001-08-10 | 2006-07-06 | Mars, Incorporated | Canine support diet |
US7514107B2 (en) * | 2002-03-21 | 2009-04-07 | Mars, Incorporated | Treatment of diseases involving defective gap junctional communication |
JP2005047851A (ja) * | 2003-07-29 | 2005-02-24 | Nisshin Pharma Inc | ユビデカレノン含有組成物 |
WO2005025322A2 (en) * | 2003-09-05 | 2005-03-24 | Hill's Pet Nutrition, Inc. | Composition for animal consumption |
BRPI0514794A (pt) * | 2004-08-30 | 2008-06-24 | Hills Pet Nutrition Inc | métodos para fornecer nutrição para um animal, para promover o bem estar de um animal, para prescrever uma dieta de bem estar para um animal, e para construir uma matriz de composições alimentìcias para um espécie animal, ração para um animal, sistema auxiliado por computador, kit, e, meio para comunicar informação sobre ou instruções para misturar e administrar uma ração |
US7595079B2 (en) * | 2005-07-08 | 2009-09-29 | Bomac Vets Plus, Inc. | Nutritional conjunctive support therapy for recovery in animals following stress or illness |
MX2008007517A (es) * | 2005-12-15 | 2009-03-04 | Nestec Sa | Composiciones y metodos para preservar la funcion cerebral. |
EP2044930A1 (en) * | 2007-10-01 | 2009-04-08 | Nestec S.A. | Composition for controlling lipase catalyzed reactions |
CN105211641A (zh) * | 2007-12-21 | 2016-01-06 | 希尔氏宠物营养品公司 | 宠物食品组合物 |
JP5513852B2 (ja) * | 2009-11-05 | 2014-06-04 | 花王株式会社 | 犬の僧帽弁閉鎖不全症及び/又は三叉弁閉鎖不全の発症リスク低減方法 |
US9415035B2 (en) * | 2010-09-17 | 2016-08-16 | Maine Natural Health Company, Inc. | Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof |
AU2012244748B2 (en) * | 2011-04-18 | 2016-07-14 | Nestec S.A. | Nutritional compositions comprising alpha-hydroxyisocaproic acid |
FR2982460B1 (fr) * | 2011-11-14 | 2016-08-05 | Virbac Sa | Produits pour administration orale comprenant des extraits de grenade punica granatum, destines a un animal de compagnie, et ses applications |
EP2931262A1 (en) * | 2012-12-14 | 2015-10-21 | Boehringer Ingelheim Vetmedica GmbH | Funny current (if) inhibitors for use in a method of treating and preventing heart disease in canine |
JP2014210761A (ja) * | 2013-04-05 | 2014-11-13 | 株式会社シバヤギ | 抗イヌn末端プロ心房性ナトリウム利尿ペプチド抗体ならびにそれを用いた免疫学的測定方法、および免疫学的測定用キット |
EP3004376B1 (en) * | 2013-06-03 | 2018-05-09 | Nestec S.A. | Methods for diagnosing chronic valvular disease |
AU2014302893B2 (en) * | 2013-06-28 | 2017-07-13 | Société des Produits Nestlé S.A. | Compositions and methods for enhancing exercise performance |
-
2017
- 2017-05-19 ES ES17727386T patent/ES2851923T3/es active Active
- 2017-05-19 US US15/600,210 patent/US20170332686A1/en not_active Abandoned
- 2017-05-19 AU AU2017267615A patent/AU2017267615B2/en active Active
- 2017-05-19 BR BR112018072064A patent/BR112018072064B8/pt active IP Right Grant
- 2017-05-19 HU HUE17727386A patent/HUE053622T2/hu unknown
- 2017-05-19 WO PCT/IB2017/052981 patent/WO2017199223A1/en unknown
- 2017-05-19 NZ NZ746681A patent/NZ746681A/en unknown
- 2017-05-19 CN CN201780029510.3A patent/CN109069465B/zh active Active
- 2017-05-19 EP EP17727386.9A patent/EP3458046B1/en active Active
- 2017-05-19 MX MX2018014083A patent/MX2018014083A/es unknown
- 2017-05-19 RU RU2018145067A patent/RU2744134C2/ru active
- 2017-05-19 JP JP2018554553A patent/JP6920343B2/ja active Active
- 2017-05-19 PL PL17727386T patent/PL3458046T3/pl unknown
- 2017-05-19 CA CA3021169A patent/CA3021169A1/en active Pending
-
2018
- 2018-10-29 CL CL2018003075A patent/CL2018003075A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
PL3458046T3 (pl) | 2021-07-05 |
CA3021169A1 (en) | 2017-11-23 |
AU2017267615A1 (en) | 2018-10-18 |
JP2019521646A (ja) | 2019-08-08 |
US20170332686A1 (en) | 2017-11-23 |
EP3458046A1 (en) | 2019-03-27 |
MX2018014083A (es) | 2019-04-04 |
EP3458046B1 (en) | 2021-01-13 |
ES2851923T3 (es) | 2021-09-09 |
BR112018072064A2 (pt) | 2019-02-12 |
WO2017199223A1 (en) | 2017-11-23 |
HUE053622T2 (hu) | 2021-07-28 |
CN109069465B (zh) | 2021-08-17 |
AU2017267615B2 (en) | 2022-03-17 |
RU2744134C2 (ru) | 2021-03-03 |
BR112018072064B1 (pt) | 2022-07-26 |
BR112018072064B8 (pt) | 2022-08-23 |
RU2018145067A3 (es) | 2020-09-11 |
RU2018145067A (ru) | 2020-06-22 |
NZ746681A (en) | 2022-07-01 |
JP6920343B2 (ja) | 2021-08-18 |
CN109069465A (zh) | 2018-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018003075A1 (es) | Composiciones nutritivas para la protección cardíaca en animales de compañía. | |
SV2018005781A (es) | Proteinas de fusión gdf15 y usos de éstas | |
CO2018012946A2 (es) | Moduladores de la vía de estrés integrada | |
CR20160212A (es) | Composiciones y métodos para modular los receptores x farnesoides | |
BR112018008877A2 (pt) | inibidores de ret | |
MX2021014617A (es) | Mitigantes quimicos en alimento para animales e ingredientes alimentarios. | |
BR112015006828A2 (pt) | composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; método para tratar uma doença em um paciente em necessidade do tratamento; e método para modular a atividade de uma proteína ire1 | |
CL2012002424A1 (es) | Método para tratar artitris reumatoide que comprende administrar al paciente laquinimod y metotrexato por vía oral; composición farmacéutica que los comprende. | |
CL2016000621A1 (es) | Formulación que comprende un adenovirus recombinante un tampón citrato hidroxipropil-beta-ciclodextrina una sal un detergente no iónico en la que dicha formulación tiene un ph que oscila entre 5.5-6,5. método de conservación de un adenovirus | |
AR081677A1 (es) | Metodos y composiciones para la administracion intratecal de iduronato-2-sulfatasa, recipiente, sistema para administracion intratecal | |
AR084581A1 (es) | Composiciones acuosas de cuidado oral | |
AR098960A1 (es) | Composiciones para el cuidado oral, prebióticas, que contienen aminoácidos, métodos, usos | |
CL2019003402A1 (es) | Composiciones sólidas para administración oral. | |
CL2015003468A1 (es) | Composicion solida para administracion oral conteniendo acido ibandronico o una sal farmaceuticamente aceptable del mismo y vitamina d. | |
AR112409A1 (es) | Composiciones capilares para tratamiento del daño | |
BR112017004393A2 (pt) | formulações de anticorpo | |
AR108291A1 (es) | Composición de nanoemulsión | |
CL2019002325A1 (es) | Combinaciones farmacéuticas para tratar cáncer. | |
UA110979C2 (uk) | Рідка фармацевтична композиція, яка включає нітизинон | |
CL2017000873A1 (es) | Composiciones y métodos para mejorar la movilidad o actividad o tratar la fragilidad | |
CL2019003072A1 (es) | Composiciones nutricionales y farmacéuticas encapsuladas. | |
CL2016003258A1 (es) | Composiciones parasiticidas que comprenden derivados de indol, métodos y usos de las mismas. | |
ECSP16058769A (es) | Composicion para la administracion oral de agente bioactivos | |
CL2019000032A1 (es) | Uso de oxido de aleno sintasa para la preservación de semen y la reproducción asistida (divisional solicitud 201603067) | |
CR20120134A (es) | Derivados de pirazol que modulan la estearoil-coa-desaturasa |